Trials / Terminated
TerminatedNCT01765114
A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes
A Phase II Open-label, Intra-individual Controlled, Single-center Study to Investigate the Efficacy, Safety and Tolerability of a Polyethylene Glycol-formulation and the Viral Shedding in Patients Suffering From Genital Herpes
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Devirex AG · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is therefore to investigate the efficacy of the PEG-formulation to reduce the frequency and duration of genital herpes recurrences, to assess its safety and tolerability and to investigate its effect on shedding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG-Formulation |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2013-01-10
- Last updated
- 2014-08-05
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01765114. Inclusion in this directory is not an endorsement.